StreetInsider.com News Articles

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Fri, 16 Oct 2026 06:00:00 -0400

Fitch Additionally Affirms Secured Debt Rating at BBB

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has affirmed Hercules’ investment grade corporate and unsecured credit rating of BBB-, and affirmed the Company’s secured debt rating of BBB, with a stable outlook, as well as its underlying analysis.

“We are very

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Fri, 16 Oct 2026 06:00:00 -0400

Fitch Additionally Affirms Secured Debt Rating at BBB

“We are very

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Fri, 16 Oct 2026 06:00:00 -0400

Fitch Additionally Affirms Secured Debt Rating at BBB

“We are very

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Fri, 16 Oct 2026 06:00:00 -0400

Fitch Additionally Affirms Secured Debt Rating at BBB

“We are very

Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

Thu, 15 Oct 2026 06:00:00 -0400

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

All interested parties are invited to participate via telephone or the

Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

Thu, 15 Oct 2026 06:00:00 -0400

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

All interested parties are invited to participate via telephone or the

Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

Thu, 15 Oct 2026 06:00:00 -0400

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

All interested parties are invited to participate via telephone or the

Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

Thu, 15 Oct 2026 06:00:00 -0400

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

All interested parties are invited to participate via telephone or the

Form 4 Hercules Capital, Inc. For: Oct 09 Filed by: Meyer Seth H

Tue, 13 Oct 2026 15:22:00 -0400

si-local-file:///var/storage/secattach/20261013/27180844.html

Form 4 Hercules Capital, Inc. For: Oct 09 Filed by: Bluestein Scott

Tue, 13 Oct 2026 15:17:00 -0400

si-local-file:///var/storage/secattach/20261013/27180825.html

Form 4 Hercules Capital, Inc. For: Oct 09 Filed by: Botelho Kiersten Zaza

Tue, 13 Oct 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20261013/27180812.html

Form 4 Hercules Capital, Inc. For: Oct 09 Filed by: Follmann Christian

Tue, 13 Oct 2026 15:12:00 -0400

si-local-file:///var/storage/secattach/20261013/27180797.html

Form 8-K Hercules Capital, Inc. For: Oct 05

Thu, 08 Oct 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20261008/27167233.html

Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029

Thu, 08 Oct 2026 16:05:00 -0400

Notes due 2029 Initially Assigned Ratings of Baa2 by Moody’s Investors Service and BBB- by Fitch Ratings, Inc.

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), today announced that it has closed an upsized underwritten public offering of $400.0 million in aggregate principal amount of 6.700% notes due October 2029 (the “Notes”).

The Notes are unsecured and bear interest at a rate of 6.700% per year, payable semiannually, will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time

Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029

Thu, 08 Oct 2026 16:05:00 -0400

Notes due 2029 Initially Assigned Ratings of Baa2 by Moody’s Investors Service and BBB- by Fitch Ratings, Inc.

The Notes are unsecured and bear interest at a rate of 6.700% per year, payable semiannually, will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time

Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029

Thu, 08 Oct 2026 16:05:00 -0400

Notes due 2029 Initially Assigned Ratings of Baa2 by Moody’s Investors Service and BBB- by Fitch Ratings, Inc.

The Notes are unsecured and bear interest at a rate of 6.700% per year, payable semiannually, will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time

Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029

Thu, 08 Oct 2026 16:05:00 -0400

Notes due 2029 Initially Assigned Ratings of Baa2 by Moody’s Investors Service and BBB- by Fitch Ratings, Inc.

The Notes are unsecured and bear interest at a rate of 6.700% per year, payable semiannually, will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time

Hercules Capital (HTGC) call put ratio 1 call to 6 puts with a focus on 3358 contracts of November 15 puts

Wed, 07 Oct 2026 14:20:06 -0400

Hercules Capital (NYSE: HTGC) 30-day option implied volatility is at 23; compared to its 52-week range of 15 to 48. Call put ratio 1 call to 6 puts with a focus on 3358 contracts of November 15 puts.

Form 424B2 Hercules Capital, Inc.

Tue, 06 Oct 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20261006/27156410.html

Rocket Pharmaceuticals secures $150M credit facility with Hercules Capital

Tue, 06 Oct 2026 16:12:14 -0400

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $150 million, according to a company press release.

Rocket received $35 million at closing. An additional $35 million may be drawn at the company's option during specified periods, subject to terms and conditions. A further $30 million may become available upon achievement of a specified clinical milestone related to its Danon disease program, and an additional $50 million is subject to Hercules' investment committee approval.

The facility carries an initial 30-month interest-only period and a 48-month maturity, with extensions available upon

Rocket Pharmaceuticals secures $150M credit facility with Hercules Capital

Tue, 06 Oct 2026 16:12:14 -0400

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $150 million, according to a company press release.

The facility carries an initial 30-month interest-only period and a 48-month maturity, with extensions available upon

Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

Tue, 06 Oct 2026 16:12:00 -0400

CRANBURY, N.J.--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that it has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $150 million. The facility strengthens Rocket’s financial position and provides access to additional capital to support execution of its pivotal Phase 2 study of RP-A501 for Danon disease and continued advancement of its broader cardiovascular pipeline.

“Building on the sale of our priority review voucher, this financing

Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

Tue, 06 Oct 2026 16:12:00 -0400

“Building on the sale of our priority review voucher, this financing

Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

Tue, 06 Oct 2026 16:12:00 -0400

“Building on the sale of our priority review voucher, this financing

Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

Tue, 06 Oct 2026 16:12:00 -0400

“Building on the sale of our priority review voucher, this financing